Omnichannel support for emerging and mid-sized biopharma

Aktana, a software company specializing in intelligent customer engagement for the life sciences industry, has released a configuration of its artificial intelligence (AI) platform that is personalized to the needs of emerging and mid-sized biopharma companies. The new Aktana Contextual Intelligence offering provides commercial teams at any sized organization with insights and content to individualize the healthcare professional (HCP) relationship.

Covid-19 has impacted the way in which HCPs interact with life sciences companies, including a move to digital channels. Rapidly growing biopharma organizations with lean resources have had to quickly adapt to this reality.

Aktana is empowering pharmaceutical businesses, such as Antares Pharma, with AI technology that is made to boost internal analytics capabilities and provide execution support in the form of a turn-key solution that can evolve as needs adjust. Using a modular AI approach, commercial teams can configure a right-size solution for identifying the right targets, predicting the ideal timing and content for maximum HCP engagement, and prioritizing next-best actions that users are most likely to adopt.